s6y

SBC Medical Group Holdings Inc

Ticker
SBC, SBCWW
CIK
1930313
Industry
Services-Offices & Clinics of Doctors of Medicine
Formerly
Pono Capital Two, Inc.

Financials 23

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K/A Annual Report for period ending Dec 31, 2025
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K/A Annual Report for period ending Dec 31, 2024
  10. 10-K/A Annual Report for period ending Dec 31, 2024

All 23 financials filings

News 48

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 48 news filings

Ownership 76

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3/A Initial statement of beneficial ownership of securities
  6. SC 13D/A Major Shareholders
  7. 4 Statement of changes in beneficial ownership of securities
  8. SC 13D/A Major Shareholders
  9. SC 13D/A Major Shareholders
  10. SC 13D Major Shareholders

All 76 ownership filings

Prospectus 17

  1. 424B7 Prospectus filed pursuant to Rule 424(b)(7)
  2. 424B7 Prospectus filed pursuant to Rule 424(b)(7)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-3 Registration statement for specified transactions by certain issuers
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 17 prospectus filings

Proxies 37

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  9. PRER14A Preliminary revised proxy soliciting materials
  10. PRER14A Preliminary revised proxy soliciting materials

All 37 proxies filings

Other 34

  1. ARS Annual report to security holders
  2. SCHEDULE 13D/A
  3. SCHEDULE 13G
  4. SCHEDULE 13D/A
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. EFFECT Notice of Effectiveness
  8. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  9. POS EX Post-effective amendment filed solely to add exhibits to a registration statement
  10. EFFECT Notice of Effectiveness

All 34 other filings